Harlan W. Waksal
Overview
Harlan W. Waksal received $5M in total compensation, including $175K in salary, at Lyra Therapeutics in 2022. Harlan Waksal also received an average of $7M at Kadmon Holdings from 2015 to 2020.
- 2022
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
Lyra TherapeuticsExecutive Chairman
Kadmon HoldingsPresident and Chief Executive Officer
Kadmon HoldingsPresident and Chief Executive Officer
Kadmon HoldingsPresident and Chief Executive Officer
Kadmon HoldingsPresident and Chief Executive Officer
Kadmon HoldingsPresident and Chief Executive Officer
Kadmon HoldingsPresident and Chief Executive Officer
Source: SEC filings on April 25, 2023, April 1, 2021, April 2, 2020, April 2, 2019, June 15, 2018, and May 10, 2017.
Related executives
We found ten more executives who work or worked at Lyra Therapeutics and Kadmon Holdings.
Maria Palasis
Lyra Therapeutics
Chief Executive Officer
Richard Nieman
Lyra Therapeutics
Chief Medical Officer
R Elsey
Lyra Therapeutics
Chief Financial Officer
Jason Cavalier
Lyra Therapeutics
Chief Financial Officer
Corinne Noyes
Lyra Therapeutics
Senior Vice President of Commercial Strategy and Market Development
Steven Meehan
Kadmon Holdings
Chief Financial Officer
Gregory Moss
Kadmon Holdings
General Counsel
Robert Richard
Lyra Therapeutics
Senior Vice President of Research and Development
News
Lyra Therapeutics Chairman Harlan Waksal receives $5M in 2022
April 25, 2023
Kadmon Holdings CFO Steven Meehan's 2020 pay jumps 76% to $2.3M
April 1, 2021
Kadmon Holdings CEO Harlan Waksal's 2019 pay jumps 27% to $4.7M
April 2, 2020
Kadmon Holdings CEO Harlan Waksal's 2018 pay jumps 43% to $3.7M
April 2, 2019